COLL Collegium Pharmaceutical, Inc. Stock Quote

COLL [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	7.74	EPS (ttm)	2.72	Insider Own	2.20%	Shs Outstand	35.30M	Perf Week	0.38%
Market Cap	740.89M	Forward P/E	4.80	EPS next Y	4.38	Insider Trans	-3.62%	Shs Float	34.17M	Perf Month	3.29%
Income	106.70M	PEG	14.08	EPS next Q	0.96	Inst Own	-	Short Float	10.86%	Perf Quarter	-14.43%
Sales	326.10M	P/S	2.27	EPS this Y	212.10%	Inst Trans	1.31%	Short Ratio	12.69	Perf Half Y	-9.42%
Book/sh	7.17	P/B	2.94	EPS next Y	19.16%	ROA	16.10%	Target Price	26.71	Perf Year	10.26%
Cash/sh	5.76	P/C	3.65	EPS next 5Y	0.55%	ROE	54.60%	52W Range	17.24 - 26.91	Perf YTD	5.14%
Dividend	-	P/FCF	7.27	EPS past 5Y	17.10%	ROI	12.50%	52W High	-21.74%	Beta	0.99
Dividend %	-	Quick Ratio	1.30	Sales past 5Y	-	Gross Margin	60.80%	52W Low	22.16%	ATR	0.50
Employees	234	Current Ratio	1.40	Sales Q/Q	6.10%	Oper. Margin	22.10%	RSI (14)	59.04	Volatility	1.75% 2.68%
Optionable	Yes	Debt/Eq	1.08	EPS Q/Q	680.60%	Profit Margin	32.70%	Rel Volume	0.24	Prev Close	21.05
Shortable	Yes	LT Debt/Eq	0.89	Earnings	Aug 05 AMC	Payout	0.00%	Avg Volume	292.50K	Price	21.06
Recom	2.10	SMA20	2.97%	SMA50	4.27%	SMA200	-7.17%	Volume	69,380	Change	0.05%

Aug-06-21

Downgrade

Cantor Fitzgerald

Overweight → Neutral

Jan-11-21

Reiterated

H.C. Wainwright

Buy

$29 → $33

Jul-14-20

Initiated

BWS Financial

Sell

May-27-20

Initiated

Guggenheim

Neutral

Feb-19-20

Resumed

Jefferies

Buy

$43

Oct-30-19

Reiterated

Needham

Buy

$33 → $25

May-03-19

Resumed

H.C. Wainwright

Buy

$23

Apr-12-19

Resumed

Janney

Buy

$29

Mar-20-19

Initiated

SunTrust

Hold

$22

Jan-16-19

Reiterated

Needham

Buy

$35 → $33

Mar-08-18

Reiterated

H.C. Wainwright

Buy

$21 → $33

Feb-07-18

Reiterated

Needham

Buy

$28 → $35

Dec-05-17

Reiterated

Needham

Buy

$25 → $28

Sep-11-17

Initiated

H.C. Wainwright

Buy

$21

May-11-17

Reiterated

Needham

Buy

$28 → $25

Sep-13-16

Initiated

Gabelli & Co

Buy

$25

Jun-01-15

Initiated

Piper Jaffray

Overweight

$26

Jun-01-15

Initiated

Needham

Buy

$28

Jun-01-15

Initiated

Jefferies

Buy

$20

Oct-21-21 04:01PM	Collegium to Host Conference Call to Discuss Third Quarter 2021 Financial Results and Provide Corporate Update GlobeNewswire
Oct-15-21 08:49AM	10 Best Biotech Stocks to Buy According to Joseph Edelmans Perceptive Advisors Insider Monkey
Sep-28-21 08:24AM	6 High Earnings Yield Picks That You Shouldn't Miss Out On Zacks
Sep-20-21 11:40AM	COLL vs. ZTS: Which Stock Should Value Investors Buy Now? Zacks
Sep-14-21 12:51PM	Top Pharmaceutical Stocks for Q4 2021 Investopedia
Sep-13-21 08:00AM	Collegium Announces Four Posters Presented at PAINWeek 2021 National Conference GlobeNewswire
Sep-01-21 04:01PM	Collegium to Participate in Upcoming Investor Conferences GlobeNewswire
Aug-16-21 08:00AM	Collegium Announces $100 Million Share Repurchase Program GlobeNewswire +14.54%
Aug-06-21 09:00AM	Collegium Pharmaceutical, inc (COLL) Q2 2021 Earnings Call Transcript Motley Fool -17.31%
Aug-05-21 06:25PM	Collegium Pharmaceutical (COLL) Q2 Earnings and Revenues Miss Estimates Zacks
04:01PM	Collegium Reports Strong Q2 Results with Cash Balance Growing to Over $200 Million GlobeNewswire
Aug-04-21 03:06AM	Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 25% Impressive? Simply Wall St.
Jul-29-21 03:04PM	Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Jun-16-21 04:01PM	Collegium Announces Publication of Real-World Data in Journal of Pain Research GlobeNewswire
Jun-02-21 01:00PM	Under Biden's Budget, These 2 Little-Known Biotechs Could Help End the Opioid Crisis Motley Fool
May-20-21 04:05PM	Collegium to Participate in Upcoming Investor Conference GlobeNewswire
May-06-21 08:31PM	Collegium Pharmaceutical Inc (COLL) Q1 2021 Earnings Call Transcript Motley Fool
06:20PM	Collegium Pharmaceutical (COLL) Beats Q1 Earnings and Revenue Estimates Zacks
04:01PM	Collegium Reports Record Quarterly Revenue of $87.7 Million GlobeNewswire
02:45PM	Collegium Pharmaceutical, Inc. to Host Earnings Call ACCESSWIRE
03:22AM	If You Had Bought Collegium Pharmaceutical (NASDAQ:COLL) Stock Five Years Ago, You Could Pocket A 47% Gain Today Simply Wall St.
Apr-29-21 05:03PM	Collegium Pharmaceutical (COLL) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Apr-15-21 04:01PM	Collegium to Host Conference Call to Discuss First Quarter 2021 Financial Results and Provide Corporate Update GlobeNewswire
Feb-26-21 08:01AM	Collegium Pharmaceutical Inc (COLL) Q4 2020 Earnings Call Transcript Motley Fool -9.37%
Feb-25-21 04:01PM	Collegium Reports Record Full-Year 2020 Revenue of $310.0 Million GlobeNewswire
02:30PM	Collegium Pharmaceutical, Inc. to Host Earnings Call ACCESSWIRE
Feb-24-21 10:27AM	Collegium Pharmaceutical's Earnings Outlook Benzinga +6.44%
Feb-11-21 04:01PM	Collegium to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and Provide Corporate Update GlobeNewswire
Feb-09-21 06:31PM	Why Collegium Pharmaceutical Rose Nearly 10% on Tuesday Motley Fool +9.75%
Feb-08-21 06:49PM	Monolithic Power Systems Set to Join S&P 500; Iridium Communications to Join S&P MidCap 400; Collegium Pharmaceutical to Join S&P SmallCap 600 PR Newswire
Jan-06-21 04:01PM	Collegium Provides 2021 Financial Guidance GlobeNewswire +6.99%
Dec-16-20 05:48PM	Is COLL A Good Stock To Buy Now? Insider Monkey
Nov-07-20 08:36AM	Results: Collegium Pharmaceutical, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts Simply Wall St.
Nov-06-20 10:31PM	Collegium Pharmaceutical Inc (COLL) Q3 2020 Earnings Call Transcript Motley Fool
Nov-05-20 05:45PM	Collegium Pharmaceutical (COLL) Tops Q3 Earnings and Revenue Estimates Zacks
04:01PM	Collegium Reports Net Income of $11.3 Million in the Third Quarter of 2020 GlobeNewswire
02:45PM	Collegium Pharmaceutical, Inc. to Host Earnings Call ACCESSWIRE
06:45AM	Can You Imagine How Collegium Pharmaceutical's (NASDAQ:COLL) Shareholders Feel About The 51% Share Price Increase? Simply Wall St.
Oct-29-20 12:35PM	Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Oct-26-20 08:00AM	Collegium Announces Publication of Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza® ER in Pain Medicine GlobeNewswire
Oct-25-20 07:05AM	Investing $5,000 in These 2 Biotechs Could Make You Rich Motley Fool
Oct-22-20 04:01PM	Collegium to Host Conference Call to Discuss Third Quarter 2020 Financial Results and Provide Corporate Update GlobeNewswire
Oct-12-20 01:25PM	Collegium Pharmaceutical Inc (COLL): Hedge Funds Taking Some Chips Off The Table Insider Monkey
Oct-04-20 06:51AM	3 Top Healthcare Stocks You Can Buy Now for Less Than $40 Motley Fool
Sep-30-20 08:00AM	Collegium Announces Settlement with Teva Resolving Xtampza® ER Patent Litigation GlobeNewswire
Sep-25-20 08:00AM	Collegium Appoints Rita Balice-Gordon to its Board of Directors GlobeNewswire
Sep-14-20 08:00AM	Collegium Announces Five Posters Presented at PAINWeek 2020 National Conference GlobeNewswire
Sep-09-20 04:05PM	Collegium Announces Scientific Presentations at PAINWeek 2020 National Conference GlobeNewswire
Aug-07-20 11:39AM	Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Could Be 32% Below Their Intrinsic Value Estimate Simply Wall St.
Aug-05-20 07:15PM	Collegium Pharmaceutical (COLL) Q2 Earnings Miss Estimates Zacks
04:01PM	Collegium Reports Net Income of $8.1 Million in the Second Quarter of 2020 GlobeNewswire
Aug-04-20 12:04PM	Collegium Pharmaceutical's Earnings: A Preview Benzinga
Aug-03-20 12:59PM	Did Hedge Funds Make The Right Call On Collegium Pharmaceutical Inc (COLL) ? Insider Monkey +5.51%
Jul-29-20 12:33PM	Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy? Zacks
Jul-21-20 05:00PM	Collegium to Host Conference Call to Discuss Second Quarter 2020 Financial Results and Provide Corporate Update GlobeNewswire
05:00PM	Collegium to Host Conference Call to Discuss Second Quarter 2020 Financial Results and Provide Corporate Update GlobeNewswire
Jul-07-20 11:40AM	AMRX vs. COLL: Which Stock Should Value Investors Buy Now? Zacks
Jun-19-20 11:40AM	AMRX vs. COLL: Which Stock Should Value Investors Buy Now? Zacks
09:57AM	Hedge Funds Keep Buying Collegium Pharmaceutical Inc (COLL) Insider Monkey
Jun-17-20 05:09PM	Collegium Pharmaceutical Named one of Boston Business Journals 2020 Best Places to Work GlobeNewswire
Jun-03-20 11:40AM	AMRX or COLL: Which Is the Better Value Stock Right Now? Zacks
May-27-20 08:44AM	Edited Transcript of COLL earnings conference call or presentation 7-May-20 8:30pm GMT Thomson Reuters StreetEvents
May-18-20 11:40AM	AMRX or COLL: Which Is the Better Value Stock Right Now? Zacks +6.72%
May-13-20 11:06AM	2 Value Stocks That Will Make You Richer in May Motley Fool -7.32%
May-08-20 12:31PM	Collegium Pharmaceutical Inc (COLL) Q1 2020 Earnings Call Transcript Motley Fool +5.61%
06:36AM	The Collegium Pharmaceutical (NASDAQ:COLL) Share Price Is Up 116% And Shareholders Are Boasting About It Simply Wall St.
May-07-20 04:01PM	Collegium Reports First Quarter 2020 Profitability GlobeNewswire
Apr-30-20 12:34PM	Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Apr-23-20 04:01PM	Collegium to Host Conference Call to Discuss First Quarter 2020 Financial Results and Provide Corporate Update GlobeNewswire
Apr-07-20 04:01PM	Collegium to Participate in Upcoming Investor Conference GlobeNewswire
Apr-06-20 09:30AM	Top Ranked Growth Stocks to Buy for April 6th Zacks +8.87%
Apr-01-20 08:50AM	Top Ranked Growth Stocks to Buy for April 1st Zacks -5.14%
Mar-26-20 11:40AM	COLL or NBIX: Which Is the Better Value Stock Right Now? Zacks
Mar-24-20 05:03AM	Edited Transcript of COLL earnings conference call or presentation 27-Feb-20 9:30pm GMT Thomson Reuters StreetEvents +17.12%
Mar-20-20 07:44AM	Top Ranked Growth Stocks to Buy for March 20th Zacks
Mar-10-20 11:40AM	COLL or NBIX: Which Is the Better Value Stock Right Now? Zacks
08:42AM	Why Collegium (COLL) Could Be an Impressive Growth Stock Zacks
Feb-27-20 04:01PM	Collegium Reports Full-Year 2019 Revenue of $296.7 Million GlobeNewswire
Feb-26-20 01:05PM	Collegium to Host Conference Call to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Provide Corporate Update GlobeNewswire
Feb-20-20 12:31PM	Earnings Preview: Collegium Pharmaceutical (COLL) Q4 Earnings Expected to Decline Zacks
Feb-13-20 04:01PM	Collegium Announces Closing of the Nucynta Franchise Acquisition GlobeNewswire
Feb-10-20 07:15PM	Collegium Pharmaceutical, Inc. Prices $125.0 Million Convertible Senior Notes Offering GlobeNewswire -15.05%
07:20AM	Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering GlobeNewswire
Feb-08-20 07:04AM	What Kind Of Share Price Volatility Should You Expect For Collegium Pharmaceutical, Inc. (NASDAQ:COLL)? Simply Wall St.
Feb-07-20 07:32AM	The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns Benzinga +25.37%
Feb-06-20 04:01PM	Collegium to Acquire U.S. Rights to Nucynta Franchise GlobeNewswire
Jan-31-20 05:00PM	Biohaven Appoints Michael Heffernan To Board Of Directors PR Newswire
Jan-21-20 08:41AM	Prospects Appear Bright for Small Drug Industry in 2020 Zacks -7.90%
Jan-14-20 11:50AM	Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now? Zacks
Jan-09-20 08:39AM	The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results Benzinga
Jan-08-20 08:12AM	The Daily Biotech Pulse: Verastem In-Licenses Chughai's Tumor Drug, Midatech Surges On Positive Study Results Benzinga +11.04%
Jan-07-20 04:05PM	Collegium Provides 2020 Financial Guidance GlobeNewswire
Dec-13-19 11:32AM	These Hedge Funds Cashed Out Of Collegium Pharmaceutical Inc (COLL) Too Early Insider Monkey
Dec-10-19 05:43PM	Edited Transcript of COLL earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Dec-06-19 02:39PM	Hedge Funds Love Unisys Corporation (UIS) Way More Than These 4 Stocks Insider Monkey
Nov-26-19 08:01AM	Collegium to Participate in Upcoming Investor Conferences GlobeNewswire
Nov-08-19 08:14AM	The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut Benzinga +10.89%
08:00AM	Collegium to Participate in Upcoming Investor Conference GlobeNewswire
Nov-06-19 06:25PM	Collegium Pharmaceutical (COLL) Reports Q3 Loss, Misses Revenue Estimates Zacks
04:01PM	Collegium Reports Third Quarter 2019 Financial Results GlobeNewswire

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ciaffoni Joseph	President and CEO	Jun 02	Sale	22.81	5,861	133,689	267,774	Jun 03 04:16 PM
Ciaffoni Joseph	President and CEO	Jun 01	Option Exercise	8.22	16,205	133,205	289,840	Jun 03 04:16 PM
Ciaffoni Joseph	President and CEO	Jun 01	Sale	23.20	16,205	375,912	273,635	Jun 03 04:16 PM
Kuhlmann Shirley R.	EVP and General Counsel	May 10	Sale	22.77	7,000	159,390	89,990	May 12 04:06 PM
Heffernan Michael Thomas	Director	Mar 15	Sale	25.30	50,075	1,266,774	4,047	Mar 17 04:03 PM
Ciaffoni Joseph	President and CEO	Mar 01	Option Exercise	8.22	48,616	399,624	343,075	Mar 03 08:02 PM
Ciaffoni Joseph	President and CEO	Mar 01	Sale	22.67	64,768	1,468,425	278,307	Mar 03 08:02 PM
Fleming Alison B	Chief Technical Officer	Mar 01	Sale	23.36	6,011	140,417	148,753	Mar 03 08:01 PM
Dreyer Scott	EVP & Chief Commercial Officer	Feb 11	Sale	25.21	7,898	199,132	83,258	Feb 12 04:16 PM
Kuhlmann Shirley R.	EVP and General Counsel	Jan 20	Sale	24.45	6,081	148,680	103,582	Jan 21 04:29 PM
Dreyer Scott	EVP & Chief Commercial Officer	Jan 15	Sale	22.89	1,322	30,261	44,395	Jan 20 04:15 PM
Fleming Alison B	Chief Technology Officer	Jan 07	Option Exercise	5.73	16,042	91,921	127,461	Jan 11 05:06 PM
Fleming Alison B	Chief Technology Officer	Jan 07	Sale	22.00	16,042	352,924	111,419	Jan 11 05:06 PM
Fleming Alison B	Chief Technology Officer	Dec 03	Sale	19.24	5,967	114,805	111,419	Dec 07 04:03 PM
Fleming Alison B	Chief Technology Officer	Nov 18	Option Exercise	5.73	16,000	91,680	117,386	Nov 20 04:28 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience